agilon health, inc. (AGL) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
AGL currently has 16.7M outstanding shares. with limited dilution risk as only 680K additional shares (4.1%) are authorized for issuance. The company has minimally diluted shareholders by 1.43% over the past 2 years. Recent corporate actions include 1 stock split (positive for accessibility) and 1 reverse split (concerning signal).
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| May 06, 2026 |
10-Q filing | 16.7M shares outstanding |
17M | 680K |
| Mar 30, 2026 |
Stock Split
8-K filing: Stock split 1-for-25 | Outstanding: 414,465,000 → 16,578,600 |
17M | 27K |
| Nov 04, 2025 |
10-Q filing | 414.5M shares outstanding |
410M | 17M |
| Aug 04, 2025 |
10-Q filing | 413.8M shares outstanding |
410M | 17M |
| May 06, 2025 |
10-Q filing | 412.9M shares outstanding |
410M | 17M |
| Feb 25, 2025 |
10-K filing | 411.0M shares outstanding |
410M | 17M |
| Nov 07, 2024 |
10-Q filing | 411.6M shares outstanding |
410M | 17M |
| Aug 06, 2024 |
10-Q filing | 411.3M shares outstanding |
410M | 17M |
| May 07, 2024 |
10-Q filing | 413.4M shares outstanding |
410M | 17M |
| Feb 27, 2024 |
10-K filing | 408.9M shares outstanding |
410M | 17M |
| Nov 02, 2023 |
10-Q filing | 405.8M shares outstanding |
410M | 17M |
| Aug 03, 2023 |
10-Q filing | 410.3M shares outstanding |
410M | 17M |
| May 09, 2023 |
10-Q filing | 413.1M shares outstanding |
410M | 17M |
| Mar 01, 2023 |
10-K filing | 408.2M shares outstanding |
410M | 17M |
| Nov 03, 2022 |
10-Q filing | 411.1M shares outstanding |
410M | 17M |
| Aug 04, 2022 |
10-Q filing | 407.3M shares outstanding |
410M | 17M |
| May 05, 2022 |
10-Q filing | 402.0M shares outstanding |
400M | 17M |
| Mar 03, 2022 |
10-K filing | 401.2M shares outstanding |
400M | 17M |
| Oct 28, 2021 |
10-Q filing | 393.7M shares outstanding |
390M | 17M |
| Sep 07, 2021 |
S-1/A filing: The filing is an S-1/A amendment related to a previous IPO, registering the sale of additional shares of common stock. It discusses the potential impact of these sales on the market price and the lock-up agreements in place for existing shareholders. |
390M | 17M |
| Aug 04, 2021 |
10-Q filing | 390.9M shares outstanding |
390M | 0 |
| May 26, 2021 |
10-Q filing | 390.8M shares outstanding |
390M | 0 |
| Apr 07, 2021 |
S-1/A filing: This S-1/A filing describes a proposed offering where cornerstone investors have indicated an interest in purchasing up to $500 million in shares. The company has applied to list its common stock on the NYSE under the symbol AGL. |
N/A | 0 |